 |
0 Diseases |  |
77 Trials |
|
77 Trials |  |
6639 News |  |
| «12...73747576777879808182838485» |
- furosemide / Generic mfg.
Enrollment change: Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis (clinicaltrials.gov) - Nov 28, 2016
P=N/A, N=200, Recruiting, Sponsor: University Hospital Inselspital, Berne
N=300 --> 200
- furosemide / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: DRAFFT: Delayed Renal Allograft Function and Furosemide Treatment (clinicaltrials.gov) - Nov 25, 2016
P2, N=0, Withdrawn, Sponsor: Loma Linda University
N=300 --> 200 N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2018 --> Oct 2016
- |||||||||| furosemide / Generic mfg.
New P3 trial, P3 data: A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts (clinicaltrials.gov) - Nov 23, 2016
P3, N=400, Not yet recruiting, Sponsor: Cutanea Life Sciences, Inc.
- | furosemide / Generic mfg.
New P4 trial: Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy (clinicaltrials.gov) - Nov 8, 2016
P4, N=144, Not yet recruiting, Sponsor: University of South Florida
- tolvaptan / Generic mfg., furosemide / Generic mfg.
Trial primary completion date: AQUA-AHF: Aquaresis Utility for Hyponatremic Acute Heart Failure Study (clinicaltrials.gov) - Oct 26, 2016
P4, N=50, Recruiting, Sponsor: University of Southern California
N=120 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2018 --> Oct 2016 Trial primary completion date: Dec 2016 --> Dec 2017
- furosemide / Generic mfg.
Trial completion: FADE: Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial (clinicaltrials.gov) - Oct 11, 2016
P3, N=46, Completed, Sponsor: Hamilton Health Sciences Corporation
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed
- furosemide / Generic mfg.
Enrollment open, Trial primary completion date: DIVERSION-HF: A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen (clinicaltrials.gov) - Oct 5, 2016
P1/2, N=10, Recruiting, Sponsor: Todd M Koelling, MD
Recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2016 --> Mar 2017
- furosemide / Generic mfg.
Trial primary completion date: FFAKI: Forced Fluid Removal in High Risk Acute Kidney Injury (clinicaltrials.gov) - Sep 22, 2016
P4, N=50, Recruiting, Sponsor: Nordsjaellands Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2016 --> Mar 2017 Trial primary completion date: Oct 2016 --> Apr 2017
- metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
Enrollment closed: Transporter Cocktail Mutual Interaction (clinicaltrials.gov) - Sep 13, 2016
P1, N=30, Active, not recruiting, Sponsor: Boehringer Ingelheim
Trial primary completion date: Oct 2016 --> Apr 2017 Recruiting --> Active, not recruiting
- furosemide / Generic mfg.
Trial primary completion date: Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure (clinicaltrials.gov) - Sep 8, 2016
P4, N=160, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting Trial primary completion date: Jul 2016 --> Jul 2017
- furosemide / Generic mfg.
Trial primary completion date: ROPA-DOP: Diuretics and Dopamine in Heart Failure With Preserved Ejection Fraction (clinicaltrials.gov) - Sep 7, 2016
P4, N=120, Recruiting, Sponsor: Johns Hopkins University
Trial primary completion date: Jul 2016 --> Jul 2017 Trial primary completion date: Jun 2016 --> Dec 2016
- furosemide / Generic mfg., spironolactone / Generic mfg.
Enrollment change, Trial withdrawal: A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II) (clinicaltrials.gov) - Sep 7, 2016
P=N/A, N=0, Withdrawn, Sponsor: Yonsei University
Trial primary completion date: Jun 2016 --> Dec 2016 N=60 --> 0 | Recruiting --> Withdrawn
- metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
Enrollment open: Transporter Cocktail Mutual Interaction (clinicaltrials.gov) - Sep 1, 2016
P1, N=30, Recruiting, Sponsor: Boehringer Ingelheim
N=60 --> 0 | Recruiting --> Withdrawn Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
New P1 trial: FurosAH: Specificity of Dyspnoea Relief With Inhaled Furosemide (clinicaltrials.gov) - Aug 28, 2016
P1, N=16, Completed, Sponsor: Oxford Brookes University
- furosemide / Generic mfg.
New P1 trial: SUBQ-Pilot: Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot (clinicaltrials.gov) - Aug 23, 2016
P1, N=40, Not yet recruiting, Sponsor: Adrian Hernandez
- furosemide / Generic mfg.
Trial primary completion date: Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis (clinicaltrials.gov) - Aug 19, 2016
P=N/A, N=300, Recruiting, Sponsor: University Hospital Inselspital, Berne
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2016 --> Sep 2017
- furosemide / Generic mfg.
Trial completion, Phase classification: J-MELODIC: Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure (clinicaltrials.gov) - Aug 19, 2016
P4, N=320, Completed, Sponsor: Hyogo College of Medicine
Trial primary completion date: Sep 2016 --> Sep 2017 Active, not recruiting --> Completed | Phase classification: PN/A --> P4
- furosemide / Generic mfg.
New trial: PYPARK: Identification of a New Metabolite of Furosemide in Humans (clinicaltrials.gov) - Aug 19, 2016
P=N/A, N=30, Completed, Sponsor: Henri Mondor University Hospital
- furosemide / Generic mfg.
Trial primary completion date: FADE: Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial (clinicaltrials.gov) - Aug 17, 2016
P3, N=50, Recruiting, Sponsor: Hamilton Health Sciences Corporation
Active, not recruiting --> Completed | Phase classification: PN/A --> P4 Trial primary completion date: Apr 2016 --> Oct 2016
- furosemide / Generic mfg., spironolactone / Generic mfg.
Trial primary completion date, Metastases: Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC) (clinicaltrials.gov) - Aug 10, 2016
P2, N=120, Recruiting, Sponsor: Centre Oscar Lambret
Trial primary completion date: Apr 2016 --> Oct 2016 Trial primary completion date: Jun 2017 --> Jun 2018
- | metformin / Generic mfg., digoxin / Generic mfg., furosemide / Generic mfg.
New P1 trial: Transporter Cocktail Mutual Interaction (clinicaltrials.gov) - Aug 3, 2016
P1, N=30, Not yet recruiting, Sponsor: Boehringer Ingelheim
- furosemide / Generic mfg., isosorbide dinitrate / Generic mfg.
Trial initiation date, Trial primary completion date: Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF (clinicaltrials.gov) - Jul 29, 2016
P=N/A, N=174, Not yet recruiting, Sponsor: Chinese University of Hong Kong
Trial primary completion date: Jun 2017 --> Jun 2018 Initiation date: Jan 2016 --> Jan 2017 | Trial primary completion date: Jun 2017 --> Dec 2017
- furosemide / Generic mfg.
Trial primary completion date: Aerosol Inhalation Treatment for Dyspnea - Patients (clinicaltrials.gov) - Jul 23, 2016
P1/2, N=55, Recruiting, Sponsor: Beth Israel Deaconess Medical Center
Initiation date: Jan 2016 --> Jan 2017 | Trial primary completion date: Jun 2017 --> Dec 2017 Trial primary completion date: Apr 2016 --> Oct 2016
- furosemide / Generic mfg.
Enrollment closed, Trial primary completion date: Aerosol Inhalation Treatment for Dyspnea (clinicaltrials.gov) - Jul 23, 2016
P1/2, N=15, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: Apr 2016 --> Oct 2016 Completed --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
- furosemide / Generic mfg.
Enrollment open: Transfusion-Associated Circulatory Overload Best Eliminated With Lasix (clinicaltrials.gov) - Jul 18, 2016
P0, N=80, Recruiting, Sponsor: Sunnybrook Health Sciences Centre
Completed --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 Not yet recruiting --> Recruiting
- | bisoprolol / Generic mfg.
New P4 trial: ResHypOT: Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension (clinicaltrials.gov) - Jul 14, 2016
P4, N=80, Recruiting, Sponsor: Sao Jose do Rio Preto University
- furosemide / Generic mfg.
Enrollment status: Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients (clinicaltrials.gov) - Jul 13, 2016
P=N/A, N=270, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
Not yet recruiting --> Recruiting Enrolling by invitation --> Recruiting
- furosemide / Generic mfg.
New P2 trial: Metabolic Effects of Furosemide +HSS in Refractory Ascites (clinicaltrials.gov) - Jul 1, 2016
P2, N=40, Completed, Sponsor: University of Palermo
- furosemide / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction (clinicaltrials.gov) - Jun 28, 2016
P=N/A, N=0, Withdrawn, Sponsor: Tel-Aviv Sourasky Medical Center
Enrolling by invitation --> Recruiting N=30 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Oct 2013 --> Jun 2013
- furosemide / Generic mfg.
Enrollment status, Trial primary completion date: Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients (clinicaltrials.gov) - Jun 27, 2016
P=N/A, N=270, Enrolling by invitation, Sponsor: Hospital de Clinicas de Porto Alegre
N=30 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Oct 2013 --> Jun 2013 Recruiting --> Enrolling by invitation | Trial primary completion date: Mar 2015 --> Aug 2016
- furosemide / Generic mfg.
Trial primary completion date: The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury (clinicaltrials.gov) - Jun 24, 2016
P=N/A, N=200, Recruiting, Sponsor: University of Chicago
Recruiting --> Enrolling by invitation | Trial primary completion date: Mar 2015 --> Aug 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- furosemide / Generic mfg.
New trial: Performance of Diuretic Stress Test in Predicting Short Term Renal Recovery in Oliguric Critically-ill Patients Recovery in the Short Term (clinicaltrials.gov) - Jun 16, 2016
P=N/A, N=200, Recruiting, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
- furosemide / Generic mfg.
New trial: Transfusion-Associated Circulatory Overload Best Eliminated With Lasix (clinicaltrials.gov) - Jun 16, 2016
P0, N=80, Not yet recruiting, Sponsor: Sunnybrook Health Sciences Centre
- | dobutamine / Generic mfg., furosemide / Generic mfg.
New P4 trial: PRIORITY-ADHF: Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure (clinicaltrials.gov) - May 10, 2016
P4, N=148, Not yet recruiting, Sponsor: Montefiore Medical Center
- hydrochlorothiazide / Generic mfg., furosemide / Generic mfg., bumetanide / Generic mfg.
New trial: POINCARE: Effects of Fluid Balance Control in Critically Ill Patients (clinicaltrials.gov) - May 6, 2016
P=N/A, N=1716, Not yet recruiting, Sponsor: Central Hospital, Nancy, France
- furosemide / Generic mfg.
Trial primary completion date: IRIHS-REA: Impact of Rational Control of Fluid Balance in the Intensive Care Unit (clinicaltrials.gov) - May 6, 2016
P3, N=172, Recruiting, Sponsor: Nantes University Hospital
Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jul 2016 --> Jul 2017
- Enrollment closed, Enrollment change, Trial primary completion date, Surgery: Early Diuresis Following Colorectal Surgery (clinicaltrials.gov) - Apr 21, 2016
P4, N=123, Active, not recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Active, not recruiting | N=286 --> 123 | Trial primary completion date: May 2018 --> Apr 2016
- | furosemide / Generic mfg.
New trial: Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy (clinicaltrials.gov) - Apr 6, 2016
P=N/A, N=116, Recruiting, Sponsor: Chulalongkorn University
- furosemide / Generic mfg.
New P1/2 trial: DIVERSION-HF: A Study to Investigate the Safety and Efficacy of a Novel Furosemide Regimen (clinicaltrials.gov) - Mar 29, 2016
P1/2, N=10, Not yet recruiting, Sponsor: Todd M. Koelling, M.D.
- fenoldopam / Generic mfg.
Enrollment change: Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury (clinicaltrials.gov) - Mar 28, 2016
P4, N=0, Withdrawn, Sponsor: Southeast Renal Research Institute
Recruiting --> Active, not recruiting | N=286 --> 123 | Trial primary completion date: May 2018 --> Apr 2016 N=70 --> 0
- furosemide / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: Inhaled Nebulized Furosemide & Physical Activity-Related Breathlessness (clinicaltrials.gov) - Mar 22, 2016
P1, N=30, Not yet recruiting, Sponsor: McGill University
N=70 --> 0 N=24 --> 30 | Initiation date: Sep 2015 --> Apr 2016 | Trial primary completion date: Dec 2016 --> Apr 2017
- furosemide / Generic mfg.
New trial, Combination therapy, Surgery: Brain Relaxation With Mannitol and Furosemide (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=47, Completed, Sponsor: Istanbul University
- tolvaptan / Generic mfg., midodrine hydrochloride / Generic mfg.
Enrollment closed, Trial primary completion date: Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites (clinicaltrials.gov) - Mar 15, 2016
P2/3, N=50, Active, not recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
N=24 --> 30 | Initiation date: Sep 2015 --> Apr 2016 | Trial primary completion date: Dec 2016 --> Apr 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
- furosemide / Generic mfg., spironolactone / Generic mfg.
Enrollment open, Metastases: Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC) (clinicaltrials.gov) - Mar 2, 2016
P2, N=120, Recruiting, Sponsor: Centre Oscar Lambret
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Not yet recruiting --> Recruiting
- acetazolamide / Generic mfg., hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Trial primary completion date: Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema (clinicaltrials.gov) - Feb 23, 2016
P4, N=20, Completed, Sponsor: Shiraz University of Medical Sciences
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2015 --> Jun 2015
- || furosemide / Generic mfg.
New P3 trial: ReBIC-1: Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients (clinicaltrials.gov) - Feb 23, 2016
P3, N=230, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
- tolvaptan / Generic mfg.
Enrollment open: AiDing Diuresis wIth Tolvaptan (ADD-IT) (clinicaltrials.gov) - Feb 17, 2016
P1, N=30, Recruiting, Sponsor: Emory University
Trial primary completion date: Sep 2015 --> Jun 2015 Not yet recruiting --> Recruiting
- furosemide / Generic mfg.
Phase classification: MRS: The Effect of Plasma Osmolality on Brain Glutamate (clinicaltrials.gov) - Feb 9, 2016
P1, N=30, Completed, Sponsor: Yale University
Not yet recruiting --> Recruiting Phase classification: P1/2 --> P1
- furosemide / Generic mfg.
Trial initiation date, Trial primary completion date: DRAFFT: Delayed Renal Allograft Function and Furosemide Treatment (clinicaltrials.gov) - Feb 2, 2016
P2, N=120, Not yet recruiting, Sponsor: Loma Linda University
Phase classification: P1/2 --> P1 Initiation date: Jul 2015 --> Sep 2016 | Trial primary completion date: Jul 2017 --> Jul 2018
- acetazolamide / Generic mfg., hydrochlorothiazide / Generic mfg., furosemide / Generic mfg.
Trial initiation date, Trial primary completion date: Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema (clinicaltrials.gov) - Jan 27, 2016
P4, N=20, Completed, Sponsor: Shiraz University of Medical Sciences
Initiation date: Jul 2015 --> Sep 2016 | Trial primary completion date: Jul 2017 --> Jul 2018 Initiation date: Jul 2014 --> Apr 2015 | Trial primary completion date: Mar 2015 --> Sep 2015